SHANK proteins: Roles at the synapse and in autism spectrum disorder

Nature Reviews Neuroscience

Volumn 18, Issue 3, 2017, Pages 147-157

  Monteiro, Patricia ^a,b,c   Feng, Guoping ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; SCAFFOLD PROTEIN; SH3 AND MULTIPLE ANKYRIN REPEAT DOMAIN PROTEIN 1; SH3 AND MULTIPLE ANKYRIN REPEAT DOMAIN PROTEIN 2; SH3 AND MULTIPLE ANKYRIN REPEAT DOMAIN PROTEIN 3; UNCLASSIFIED DRUG; NERVE PROTEIN;

AUTISM; CENTRAL NERVOUS SYSTEM; HUMAN; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SYNAPSE; SYNAPTOGENESIS; ANIMAL; GENETICS; METABOLISM; MUTATION; NERVE CELL;

ANIMALS; AUTISM SPECTRUM DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; MUTATION; NERVE TISSUE PROTEINS; NEURONS; SYNAPSES;

EID: 85011915766     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn.2016.183     Document Type: Review

References (102)

1. Sheng, M. & Hoogenraad, C. C. The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu. Rev. Biochem. 76, 823-847 (2007).
2. Ahmari, S. E. & Smith, S. J. Knowing a nascent synapse when you see it. Neuron 34, 333-336 (2002).
3. Kano, M. & Hashimoto, K. Synapse elimination in the central nervous system. Curr. Opin. Neurobiol. 19, 154-161 (2009).
4. Sheng, M. & Kim, E. The postsynaptic organization of synapses. Cold Spring Harb. Perspect. Biol. 3, a005678 (2011).
5. Leblond, C. S. et al. Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet. 10, e1004580 (2014).
6. Gauthier, J. et al. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150, 421-424 (2009).
7. Boccuto, L. et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur. J. Hum. Genet. 21, 310-316 (2013).
8. Sala, C., Vicidomini, C., Bigi, I., Mossa, A. & Verpelli, C. Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. J. Neurochem. 135, 849-858 (2015).
9. Peça, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437-442 (2011).
10. Naisbitt, S. et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23, 569-582 (1999).
11. Wang, X., Xu, Q., Bey, A. L., Lee, Y. & Jiang, Y. Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol. Autism 5, 30 (2014).
12. Jiang, Y.-H & Ehlers, M. D. Modeling autism by SHANK gene mutations in mice. Neuron 78, 8-27 (2013).
13. Beri, S. et al. DNA methylation regulates tissue-specific expression of Shank3. J. Neurochem. 101, 1380-1391 (2007).
14. Ching, T.-T. et al. Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat. Genet. 37, 645-651 (2005).
15. Maunakea, A. K. et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466, 253-257 (2010).
16. Lim, S. et al. Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol. Cell. Neurosci. 17, 385-397 (2001).
17. Böckers, T. M. et al. Synaptic scaffolding proteins in rat brain: ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein α-fodrin. J. Biol. Chem. 276, 40104-40112 (2001).
18. Mameza, M. G. et al. SHANK3 gene mutations associated with autism facilitate ligand binding to the shank3 ankyrin repeat region. J. Biol. Chem. 288, 26697-26708 (2013).
19. Uchino, S. et al. Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synaptic molecule Shank3 with GluR1 α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor. J. Neurochem. 97, 1203-1214 (2006).
20. Tu, J. C. et al. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23, 583-592 (1999).
21. Hayashi, M. K. et al. The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 137, 159-171 (2009).
22. Baron, M. K. et al. An architectural framework that may lie at the core of the postsynaptic density. Science 311, 531-535 (2006).
23. Boeckers, T. M. et al. C-Terminal synaptic targeting elements for postsynaptic density proteins ProSAP1/Shank2 and ProSAP2/Shank3. J. Neurochem. 92, 519-524 (2005).
24. Grabrucker, A. M. et al. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 30, 569-581 (2011).
25. Guilmatre, A., Huguet, G., Delorme, R. & Bourgeron, T. The emerging role of SHANK genes in neuropsychiatric disorders. Dev. Neurobiol. 74, 113-122 (2014).
26. Boeckers, T. M., Bockmann, J., Kreutz, M. R. & Gundelfinger, E. D. ProSAP/Shank proteins-a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem. 81, 903-910 (2002).
27. Okamoto, P. M., Gamby, C., Wells, D., Fallon, J. & Vallee, R. B. Dynamin isoform-specific interaction with the Shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton. J. Biol. Chem. 276, 48458-48465 (2001).
28. McWilliams, R. R., Gidey, E., Fouassier, L., Weed, S. A. & Doctor, R. B. Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells. Biochem. J. 380, 181-191 (2004).
29. Leblond, C. S. et al. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet. 8, e1002521 (2012).
30. Schmeisser, M. J. et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486, 256-260 (2012).
31. Lim, S. et al. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J. Biol. Chem. 274, 29510-29518 (1999).
32. Peça, J., Ting, J. & Feng, G. SnapShot: autism and the synapse. Cell 147, 706-706.e1 (2011).
33. Böckers, T. M. et al. Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3? untranslated region of Shank1 mRNA. Mol. Cell. Neurosci. 26, 182-190 (2004).
34. Zitzer, H., Hönck, H. H., Bächner, D., Richter, D. & Kreienkamp, H. J. Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain. J. Biol. Chem. 274, 32997-33001 (1999).
35. Lee, J. et al. Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Front. Cell. Neurosci. 9, 94 (2015).
36. Wang, X. et al. Altered mGluR5-Homer scaffolds and corticostriatal connectivity in a Shank3 complete knockout model of autism. Nat. Commun. 7, 11459 (2016).
37. Mei, Y. et al. Adult restoration of Shank3 expression rescues selective autistic-like phenotypes. Nature 530, 481-484 (2016).
38. Lai, M. C. et al. Cognition in males and females with autism: similarities and differences. PLoS ONE 7, e47198 (2012).
39. Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ. 61, 1-19 (2012).
40. American Psychiatric Association (eds). Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association Publishing, 2013).
41. Rosenberg, R. E. et al. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch. Pediatr. Adolesc. Med. 163, 907-914 (2009).
42. Geschwind, D. H. Advances in autism. Annu. Rev. Med. 60, 367-380 (2009).
43. Huguet, G., Ey, E. & Bourgeron, T. The genetic landscapes of autism spectrum disorders. Annu. Rev. Genomics Hum. Genet. 14, 191-213 (2013).
44. Betancur, C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 1380, 42-77 (2011).
45. Toro, R. et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet. 26, 363-372 (2010).
46. Phelan, K. & McDermid, H. E. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol. Syndromol. 2, 186-201 (2012).
47. Phelan, M. C. et al. 22Q13 deletion syndrome. Am. J. Med. Genet. 101, 91-99 (2001).
48. Bonaglia, M. C. et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261-268 (2001).
49. Bonaglia, M. C. et al. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with phelan/mcdermid syndrome. PLoS Genet. 7, e1002173 (2011).
50. Wilson, H. L. et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575-584 (2003).
51. Wilson, H. L. et al. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development. Eur. J. Hum. Genet. 16, 1301-1310 (2008).
52. Moessner, R. et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81, 1289-1297 (2007).
53. Durand, C. M. et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25-27 (2007).
54. Berkel, S. et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 42, 489-491 (2010).
55. Okabe, S. Molecular anatomy of the postsynaptic density. Mol. Cell. Neurosci. 34, 503-518 (2007).
56. Emes, R. D. & Grant, S. G. N. Evolution of synapse complexity and diversity. Annu. Rev. Neurosci. 35, 111-131 (2012).
57. Boeckers, T. M. The postsynaptic density. Cell Tissue Res. 326, 409-422 (2006).
58. Montgomery, J. M., Zamorano, P. L. & Garner, C. C. MAGUKs in synapse assembly and function: an emerging view. Cell. Mol. Life Sci. 61, 911-929 (2004).
59. Sheng, M. & Kim, E. The Shank family of scaffold proteins. J. Cell Sci. 113, 1851-1856 (2000).
60. Tao-Cheng, J. H., Dosemeci, A., Gallant, P. E., Smith, C. & Reese, T. Activity induced changes in the distribution of Shanks at hippocampal synapses. Neuroscience 168, 11-17 (2010).
61. Tao-Cheng, J. H., Yang, Y., Reese, T. S. & Dosemeci, A. Differential distribution of shank and GKAP at the postsynaptic density. PLoS ONE 10, e0118750 (2015).
62. Wang, X. et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20, 3093-3108 (2011).
63. Bozdagi, O. et al. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 1, 15 (2010).
64. Yang, M. et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J. Neurosci. 32, 6525-6541 (2012).
65. Kouser, M. et al. Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J. Neurosci. 33, 18448-18468 (2013).
66. Zhou, Y. et al. Mice with Shank3 mutations associated with ASD and schizophrenia display both shared and distinct defects. Neuron 89, 147-162 (2016).
67. Hung, A. Y. et al. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J. Neurosci. 28, 1697-1708 (2008).
68. Won, H. et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486, 261-265 (2012).
69. Roussignol, G. et al. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 25, 3560-3570 (2005).
70. Sala, C. et al. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31, 115-130 (2001).
71. -/-mice. Nat. Neurosci. 19, 716-724 (2016).
72. h channelopathy in human neurons. Science 352, aaf2669 (2016).
73. Shcheglovitov, A. et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503, 267-271 (2013).
74. Gogolla, N., Takesian, A. E., Feng, G., Fagiolini, M. & Hensch, T. K. Sensory integration in mouse insular cortex reflects GABA circuit maturation. Neuron 83, 894-905 (2014).
75. Filice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M. & Schwaller, B. Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol. Brain 9, 10 (2016).
76. Lu, C. et al. Micro-electrode array recordings reveal reductions in both excitation and inhibition in cultured cortical neuron networks lacking Shank3. Mol. Psychiatry 21, 159-168 (2015).
77. Rubenstein, J. L. R. & Merzenich, M. M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255-267 (2003).
78. Bourgeron, T. A synaptic trek to autism. Curr. Opin. Neurobiol. 19, 231-234 (2009).
79. Bernhardt, B. C. & Singer, T. The neural basis of empathy. Annu. Rev. Neurosci. 35, 1-23 (2012).
80. Frith, C. D. The social brain? Phil. Trans. R. Soc. B 362, 671-678 (2007).
81. Lamm, C. & Singer, T. The role of anterior insular cortex in social emotions. Brain Struct. Funct. 214, 579-591 (2010).
82. Barak, B. & Feng, G. Neurobiology of social behavior abnormalities in autism and Williams syndrome. Nat. Neurosci. 19, 647-655 (2016).
83. Gauthier, J. et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc. Natl Acad. Sci. USA 107, 7863-7868 (2010).
84. Han, K. et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503, 72-77 (2013).
85. Silverman, J. L. et al. Sociability and motor functions in Shank1 mutant mice. Brain Res. 1380, 120-137 (2011).
86. Mao, W. et al. Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons. Eur. J. Neurosci. 41, 1025-1035 (2015).
87. Wöhr, M., Roullet, F. I., Hung, A. Y., Sheng, M. & Crawley, J. N. Communication impairments in mice lacking shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS ONE 6, e20631 (2011).
88. Lim, C.-S. et al. Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice. Neuropharmacology 112, 104-112 (2017).
89. Peter, S. et al. Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice. Nat. Commun. 7, 12627 (2016).
90. Lord, C., Cook, E. H., Leventhal, B. L. & Amaral, D. G. Autism spectrum disorders. Neuron 28, 355-363 (2000).
91. Amaral, D., Geschwind, D. & Dawson, G. Autism Spectrum Disorders (Oxford Univ. Press, 2011).
92. Swiech, L. et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102-106 (2014).
93. Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147 (2007).
94. Garg, S. K. et al. Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J. Neurosci. 33, 13612-13620 (2013).
95. Sztainberg, Y. et al. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature 528, 123-126 (2015).
96. Clement, J. P. et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151, 709-723 (2012).
97. Bidinosti, M. et al. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency. Science 351, 1199-1203 (2016).
98. Vicidomini, C. et al. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Mol. Psychiatry http://dx. doi.org/10.1038/mp.2016.30 (2016).
99. Duffney, L. J. et al. Autism-like deficits in Shank3-deficient mice are rescued by targeting actin regulators. Cell Rep. 11, 1400-1413 (2015).
100. Lee, E.-J. et al. Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation. Nat. Commun. 6, 7168 (2015).
101. Jaramillo, T. C. et al. Altered striatal synaptic function and abnormal behaviour in Shank3 Exon4-9 deletion mouse model of autism. Autism Res. 9, 350-375 (2016).
102. Speed, H. E. et al. Autism-associated insertion mutation (InsG) of Shank3 Exon 21 causes impaired synaptic transmission and behavioral deficits. J. Neurosci. 35, 9648-9665 (2015).